Monitoring of Therapeutic Response

Role of Therapeutic Response Monitoring in Rational Prescription
📌 Therapeutic response monitoring is the sixth step in the seven-step process for rational drug prescription, following diagnosis, objective setting, and drug selection.
💊 Prescription involves writing the indication, which is preceded by clear diagnosis and followed by patient instruction, and finally, the evaluation of results (monitoring).
📈 The goal of monitoring is to assess if the desired therapeutic effects (efficacy) and unwanted effects (adverse/toxic) are manifesting as expected based on prior research on the drug's mechanism of action.

Pharmacokinetics, Pharmacodynamics, and Variability
🔬 Therapeutic response is the sum of all pharmacological effects resulting from drug use, involving pharmacokinetics (how the body handles the drug to reach the site of action) and pharmacodynamics (the mechanisms and effects at the receptor site).
📊 The relationship between drug concentration at the site of action and effect is represented by dose-response curves, showing that a given dose may yield varying effects due to variability.
🔄 This variability in response is both inter-individual (differences between people) and intra-individual (changes within the same person over time due to age, pathology, or environment).

Components and Types of Monitoring
🩺 Monitoring involves observing therapeutic effects, potential adverse/toxic effects, and crucially, patient adherence/compliance to the prescribed treatment, especially in chronic conditions.
📊 Monitoring must always be clinical (based on anamnesis and physical exam), but sometimes requires paraclinical methods, including measuring plasma concentrations, for specific drugs.
🧪 Drugs requiring paraclinical monitoring, such as antiepileptics, certain antibiotics, immunomodulators, and older cardiovascular drugs like Digoxin, typically have a very narrow therapeutic range or difficulty in clinically assessing benefit (e.g., preventing an event).

When and How to Use Plasma Concentration Monitoring (TDM)
📉 Therapeutic Drug Monitoring (TDM) is used to individualize dosing when population-based reference ranges are insufficient, focusing on achieving the individual effective concentration.
⚙️ Factors necessitating TDM include drugs with a narrow therapeutic index (toxic dose is close to the therapeutic dose), saturable elimination kinetics (risk of accumulation), and the presence of significant inter-individual variability due to genetics or drug interactions.
⏳ For TDM to be valid when toxicity is *not* immediately suspected, measurements must be taken when the drug has reached steady-state concentration, which usually requires at least four to five elimination half-lives.

Key Points & Insights
➡️ Therapeutic response monitoring must be planned *at the time of prescribing* to assess efficacy, safety, and patient compliance over the course of treatment.
➡️ Clinical monitoring is systematic for all drugs, while paraclinical monitoring (TDM) is reserved for drugs with narrow ranges, complex kinetics, or difficulty in measuring clinical benefit directly.
➡️ Interpreting TDM results requires careful consideration of how the drug was administered, the timing of the sample relative to the dose, and the patient's current physiological status (e.g., renal/hepatic function).

📸 Video summarized with SummaryTube.com on Mar 07, 2026, 21:18 UTC